Various drugs manufactured by listed players like Sun Pharmaceuticals, Alkem Laboratories, Cipla Ltd, Mankind Pharma, Lupin Ltda and Torrent Pharma are included in the list.
Drugs and medical devices in the National List of Essential Medicines rise year-on-year price by 2-3 percent on average, but the increase may be steeper this year Common antibiotics and medicines for treating fever and blood pressure are among drugs whose prices are expected to increase steeply this year
The prices of drugs and medical devices in India have long been under the scanner for unaffordability to a large chunk of the population but the government now claims that it is trying to fix a trade margin ceiling for many drugs, including the ones used in COVID treatment, to make them easily accessible to people.
More essential drugs are likely to come under price control with the government expected to decide on the matter in a meeting scheduled for next week.
As far as the petition goes, the IPA has said that the NPPA has committed a contempt of court order with regard to the August 2014 order of the Bombay High Court where they said that no coercive action should be taken against any pharma company belonging to the IPA.
UR Associates has come out with its report on pharmaceutical sector. According to the research firm, the Indian Cabinet has approved the long pending National Pharmaceutical Pricing Policy, which would bring 348 drugs under the ambit of price control.
A Group of ministers (GOM) has finalised a new policy for pricing essential medicines in the country. Lets understand more what their recommendations are and what impact will it have on the industry as such.
Government wants to control prices of expensive patented medicines sold in India so that they become more affordable, especially to the poor people.
With Assembly polls just months away, the LDF Government in Kerala today presented a people-centric Budget with a focus to welfare measures, price-control programmes and infrastructure development.